1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Dual antithrombotc therapy-2: new trials by email Literature Review of Dual antithrombotc therapy-2 trials Research Report on Dual antithrombotc therapy-2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) Triple antithrombotic therapy, Dual antithrombotc therapy-1, Dual antithrombotc therapy-2 - Acute Coronary Syndrome (ACS), Non-valvular Atrial Fibrillation (NVAF) | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 3746 | 2018-02-03 | 2023-04-24 |
The First Affiliated Hospital with Nanjing Medical University (1)
China (1)